Resonance has been a presence in the API and Specialty Chemicals segment for more than 30 years. After a start in Mumbai, operations moved to Bangalore in 1984. In the 30 years, Resonance has partnered with several multinationals on custom synthesis projects and with our strengths in multi-step synthesis together with focus on quality, we have helped our customers develop their products in a timely fashion. We have brought the same discipline to our API business and in the recent years have developed some complex molecules that are produced in our cGMP plant. Our facility is WHO GMP certified and we follow cGMP as per the ICH Q7 guideline.We have registered DMFs and CEPs for some of our products and are in the process of registering more. We currently sell to the European and other markets on the basis of our DMFs and CEPs.

Complex Chemistry and Complicated Molecules: We have experience in running several reactions at lab, pilot and plant scale. We choose to work only on projects that involve multiple steps and where our research and development teams can add value. Focus on these ABCs have enabled us to develop molecules such as Atropine, Buprenorphine, and Clidinium.

Critical Attention to Customer Needs – Building “Bonds Beyond Chemistry”: Our management has experience at global corporations (including finished dose marketers) and as a result the company understands the customers' need for timeliness of deliverables and communications. In fact, our principle of “bonds beyond chemistry” is intended to reflect our aspiration of delivering not just a product or service but an experience of true partnership and value to our customer.

Focus on Employees: Another manifestation of “bonds beyond chemistry” is the strong retention policy for good talent and a comprehensive view towards employee needs beyond the company compound walls. Several employees have been with the company since its formation and company has attracted new talent in its quest for further growth.